Community pharmacies, drug stores, and antibiotic dispensing in Indonesia: A qualitative study by Ferdiana, Astri et al.
eCommons@AKU 
Community Health Sciences Department of Community Health Sciences 
9-7-2021 
Community pharmacies, drug stores, and antibiotic dispensing in 




Luh Putu Lila Wulandari 
Yusuf Ari Mashuri 
See next page for additional authors 
Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_chs_chs 
 Part of the Chemicals and Drugs Commons, and the International Public Health Commons 
Authors 
Astri Ferdiana, Marco Liverani, Mishal Khan, Luh Putu Lila Wulandari, Yusuf Ari Mashuri, Neha Batura, Tri 
Wibawa, Shunmay Yeung, Richard Day, Stephen Jan, Virginia Wiseman, and Ari Probandari 
RESEARCH Open Access
Community pharmacies, drug stores, and
antibiotic dispensing in Indonesia: a
qualitative study
Astri Ferdiana1,2, Marco Liverani3,4,5*, Mishal Khan3,6, Luh Putu Lila Wulandari7,8, Yusuf Ari Mashuri1,9, Neha Batura10,
Tri Wibawa1,11, Shunmay Yeung12, Richard Day13, Stephen Jan14, Virginia Wiseman3,7 and Ari Probandari1,9
Abstract
Background: Inappropriate dispensing of antibiotics at community pharmacies is an important driver of antimicrobial
resistance (AMR), particularly in low- and middle-income countries. Thus, a better understanding of dispensing
practices is crucial to inform national, regional, and global responses to AMR. This requires careful examination of the
interactions between vendors and clients, sensitive to the context in which these interactions take place.
Methods: In 2019, we conducted a qualitative study to examine antibiotic dispensing practices and associated
drivers in Indonesia, where self-medication with antibiotics purchased at community pharmacies and drug
stores is widespread. Data collection involved 59 in-depth interviews with staff at pharmacies and drug stores
(n = 31) and their clients (n = 28), conducted in an urban (Bekasi) and a semi-rural location (Tabalong) to
capture different markets and different contexts of access to medicines. Interview transcripts were analysed
using thematic content analysis.
Results: A common dispensing pattern was the direct request of antibiotics by clients, who walked into
pharmacies or drug stores and asked for antibiotics without prescription, either by their generic/brand name
or by showing an empty package or sample. A less common pattern was recommendation to use antibiotics
by the vendor after the patient presented with symptoms. Drivers of inappropriate antibiotic dispensing
included poor knowledge of antibiotics and AMR, financial incentives to maximise medicine sales in an
increasingly competitive market, the unintended effects of health policy reforms to make antibiotics and other
essential medicines freely available to all, and weak regulatory enforcement.
Conclusions: Inappropriate dispensing of antibiotics in community pharmacies and drug stores is the outcome of
complex interactions between vendors and clients, shaped by wider and changing socio-economic processes. In
Indonesia, as in many other LMICs with large and informal private sectors, concerted action should be taken to engage
such providers in plans to reduce AMR. This would help avert unintended effects of market competition and adverse
policy outcomes, as observed in this study.
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Introduction
Antimicrobial resistance (AMR) occurs when microbes
evolve in response to the medicines that are used to
treat them, reducing their therapeutic effectiveness. It is
estimated that drug resistant infections will cause 10
million deaths annually by 2050 if appropriate measures
are not taken [1]. In addition, infections caused by drug
resistant microbes can lead to a two-fold increase in ad-
verse outcomes in comparison with similar infections
caused by susceptible strains. Adverse outcomes may be
clinical (including death) or economic due to higher
costs of care and indirect costs associated with loss of
income [2, 3].
While AMR occurs naturally, it is accelerated by misuse
and overuse of antimicrobials worldwide [4]. Global esti-
mates indicate that 60% of antibiotics are sold without
prescription in community pharmacies [5] and self-
medication with antibiotics is a common practice, particu-
larly in low- and middle-income countries (LMICs) [6].
Thus, a better understanding of these practices is crucial
to inform national, regional, and global responses to
AMR. In turn, this requires careful examination of the
types of interactions between vendors and clients, sensi-
tive to the context in which these interactions take place.
This paper examines these interactions within the
country context of Indonesia. Surveys of antibiotic use
in Indonesia have consistently reported inappropriate
dispensing in the private sector amidst concerns about
alarming rates of AMR [7, 8]. Notably, a study in Semar-
ang province found that resistance of Streptococcus
pneumoniae to cotrimoxazole was 45% and non-
susceptibility rates to penicillin were around 24% [9].
Escherichia coli isolates from hospital discharged pa-
tients also showed high rates of resistance to ampicillin
(73%), cotrimoxazole (56%) and ciprofloxacin (22%) [10].
In light of this, the government has taken several
steps to tackle this problem, including the adoption
of the first action plan on AMR in 2017 [11]. As in
many other countries, however, AMR policy and in-
terventions in Indonesia have largely focused on the
public health system with little attention to the pri-
vate sector [12]. In addition, the evidence to inform
policy has been derived primarily from prevalence or
knowledge, attitude and practice surveys [13, 14], with
inadequate understanding of contextual drivers of
AMR and associated practices. Considering this gap
in knowledge, our paper presents findings from a
qualitative study that aimed to better understand how
and why non-prescribed antibiotics are dispensed at
community pharmacies and drug stores in Indonesia.
After a description of the research context and
methods, the following sections report the study find-
ings and discuss their implications for AMR policy in
Indonesia and similar contexts.
Private drug sellers and AMR in Indonesia
Indonesia is the fourth most populous country in the
world, with a population of more than 270 million [15].
Following decades of economic growth, the country re-
cently advanced to upper-middle income status in its
World Bank classification. Health care is delivered by a
mixed public-private health system [16]. The public
health sector is decentralised and consists of community
health centers (puskesmas) at the subdistrict level and
state hospitals at the district and provincial levels. The
private sector is large and diverse. It includes not-for-
profit faith-based organisations, for-profit private prac-
tices, clinics and hospitals, and practitioners of trad-
itional medicine. In 2014, the government introduced a
new health insurance scheme – the Jaminan Kesehatan
Nasional (JKN) - to increase access to care and move to-
wards universal health coverage. Under this scheme,
Indonesian citizens who pay the monthly premium (or
are eligible for an exemption) are entitled to receving
care and essential medicines at public health facilities
and participating private providers, including community
pharmacies [17].
Pharmacies and other private drug sellers are generally
the first port of call for around 90% of patients with mild
illness [18]. This is a prolific and dynamic business sec-
tor which includes big retail chains, independent phar-
macies (apotek), drug stores (toko obat) and unlicensed
grocery stores (warung) that also sell over-the-counter
drugs such as common cold medicines, antipyretics, and
analgesics. The expansion of this sector can be traced
back to the 1970s when President Suharto’s government
embraced economic liberalisation, opening the country
to foreign investments. In this period, more than 30
international pharmaceutical companies established op-
erations in Indonesia, and generic products began to be
manufactured locally [19]. In the 2010s, the government
implemented several pricing policies to make generic
drugs more affordable, promoting further expansion of
the pharmaceutical sector [20]. Today, it is estimated
that more than 22,000 pharmacies and 5000 licensed
drug stores operate throughout the country [21].
By Indonesian law, antibiotics can only be sold by a
pharmacist after presentation of a prescription and drug
stores are not allowed to sell antibiotics [22]. In addition,
a qualified pharmacist must always be available at phar-
macies during opening times, although ownership of a
pharmacy is not restricted to pharmacists [23]. Despite
these regulations, past studies [7, 14] and a recent survey
[8] found that inappropriate antibiotic dispensing is wide-
spread among community pharmacies and drug stores,
raising concerns about their role in promoting AMR.
In order to address these problems, in 2017 the gov-
ernment adopted a national action plan to combat AMR
in line with the WHO global guidelines. Among other
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provisions, this plan aims to improve awareness and
knowledge of AMR in the general public and among
health professionals (including pharmacists), and to
“strengthen the enforcement of regulations on anti-
microbial post-marketing surveillance” [24]. Since 2015,
the Ministry of Health has also implemented a
community-based program to promote responsible self-
medication, called the “Community Smart Use of Medi-
cation Movement” (Gerakan Masyarakat Cerdas Meng-
gunakan Obat), known as GeMa CerMat, where
pharmacists are trained to provide information on medi-
cines to their communities. Despite some progress, the
implementation of these initiatives has been slow and
private sector engagement remains a significant policy
challenge [25].
Methods
Research design and settings
The qualitative study presented here was part of a larger
study of AMR in Indonesia conducted in 2019, which
found high rates of inappropriate dispensing and poor
consultation practices at pharmacies and other drug
stores [8]. In the same study locations, we conducted in-
terviews to better understand the ‘how’ and ‘why’ of
non-prescribed antibiotic dispensing. In keeping with
the principles of phenomenology [26], the qualitative
study focused on individual experiences and perceptions
of the social actors involved in the final stage of anti-
biotic dispensing – those who sell antibiotics and their
clients. Data collection involved in-depth interviews,
conducted in an urban location (Bekasi) and a semi-
rural location (Tabalong) to capture different markets
and contexts of access to medicines and different dens-
ities of pharmacies in these locations. Bekasi is an indus-
trial area located in West Java Province and a satellite
city of the national capital Jakarta. It has a population of
about 3.5 million, largely consisting of internal migrants
and commuters from other parts of Java. Tabalong is a
district located in South Kalimantan Province with a
population of 250,000 [27]. In 2018, the number of phar-
macies in Bekasi and Tabalong was 534 and 31 respect-
ively, while the number of drug stores was 87 and 31
respectively [21].
Study participants and data collection
In both study settings, a list of all registered pharmacies
and drug stores (collectively defined here as “drug retail
outlets”, DRO) was obtained from the district health of-
fices and sorted by subdistrict. In each subdistrict, phar-
macies and/or drug stores were randomly selected from
the registry and telephoned to ask if they were willing to
take part in the study and to schedule a time to conduct
an interview. In each pharmacy and drug store, we
aimed to recruit two categories of respondents: (1)
vendors responsible for drug dispensing, including phar-
macists, shop attendants, and owners); and (2) adult cli-
ents, who were approached and invited to participate in
the interview after they had completed their interaction
with the vendor.
All interviews were conducted face-to-face in Indones-
ian (Bahasa Indonesia) by the first author and other
Indonesian researchers with training in social research
methods using a semi-structured topic guide, tailored to
each category of participants. Most interviews with ven-
dors focused on: the type of business; supply and sales of
antibiotics; antibiotic dispensing practices; awareness of
antibiotic resistance; and awareness of regulations and
compliance. Interviews with clients mainly focused on
health seeking behaviour and their use and knowledge of
antibiotics. After each interview, summary notes were
taken to refine the interview guidelines for the following
interviews and to determine saturation. All interviews
were audio-recorded and lasted between 25 and 70 min.
The interviews were conducted in August and Septem-
ber 2019.
Data management and analysis
The interviews were transcribed verbatim and processed
to generate an initial set of codes after iterative, induct-
ive reading of the transcripts. The coding scheme was
subsequently reviewed and refined after discussion with
the study team to reduce subjective biases. The analysis
was informed by two main concerns: to understand the
types of interactions leading to inappropriate dispensing
of antibiotics; and to explore factors shaping these inter-
actions and their outcomes. Thematic content analysis
and coding were performed using NVivo version 9.
Results
Overview
In total, interviews were conducted at 21 pharmacies
and 10 drug stores. As detailed in Table 1, 31 interviews
Table 1 Study sample
Bekasi Tabalong Total
Pharmacies
Owner 3 2 5
Pharmacist 2 1 3
Owner and pharmacist 7 5 12
Pharmacy attendant 2 – 2
Client 13 11 24
Drug stores
Owner 1 6 7
Drug store attendant 1 1 2
Client 2 2 4
Total 31 28 59
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were conducted with vendors (owners, pharmacists, and
attendants) and 28 with adult clients in the 19–65 age
range. In Bekasi, pharmacies and drug stores of different
types and size were clustered near clinics or residential
complexes or lined along the main city roads. In Taba-
long, most pharmacies were located near the district
centre although a few drug stores were in peripheral
areas. The majority of DROs were small independent
businesses serving about 15 to 20 customers every day;
only a few pharmacies in Bekasi were part of retail
chains. By Indonesian law, pharmacies and drug stores
must supply medicines, including antibiotics, from
wholesale distributors. However, a few pharmacists ad-
mitted they would regularly restock at large retail
pharmacies since these would offer better deals and, un-
like wholesalers, would not apply minimum order
requirements.
Pharmacists in both locations explained that people
often medicate with drugs purchased at their stores be-
cause they have little money to pay for a private doctor
or little time to visit a public health centre, where they
often have to wait in long queues:
“Well frankly… if they go to the doctor, they will
be charged 75,000 or 100,000 rupiah [US$ 5-7]
for the consultation. That’s quite a lot. If they
come to my place, they can get some information
about how the medicine works, and they don’t
have to pay that much… that’s why they like it.”
(Male pharmacist, Bekasi, V05B).
Similarly, clients said that pharmacies and drug stores
are more accessible than public health facilities and open
in the evening:
“It takes time to go to the primary health centre. It’s
far, then we have to wait. I only visit the health
centre if I feel really sick.” (Male client, 29, Taba-
long, C03T)
“I don’t have time to go to the health centre in the
morning (…) I must work.” (Female client, 54,
Bekasi, C05B)
In this context, antibiotics could be easily purchased
without prescription at both pharmacies and drug
stores:
“Is it easy to get antibiotics? Well… you can find
them everywhere.” (Male client, 33, Bekasi, C02B)
“Maybe 10% of my sales are antibiotics, and the pro-
portions of prescribed and non-prescribed
antibiotics is about 30 and 70%.” (Female pharma-
cist, Bekasi, V012B)
“Drug stores are not supposed to keep antibiotics,
but they often sell ampicillin and amoxicillin. Some-
times they also sell ciprofloxacin and cefadroxil al-
though this is less common.” (Male owner/
pharmacist, Tabalong, V01T)
“It is so easy to get [unprescribed] antibiotics
here… sometimes even the small vendors around
here have them.” (Male owner/pharmacist, Taba-
long, V01T)
In the following sections, in line with the study objec-
tives, we will describe the interactions leading to in-
appropriate antibiotic dispensing and their drivers.
Antibiotic dispensing patterns
A common pattern of non-prescribed antibiotic dispens-
ing was the direct request of antibiotics by clients as part
of a self-medication strategy, based on previous experi-
ences in the public sector or advice from relatives or
friends. As reported by vendors, many clients walked
into their pharmacy or drug store and ordered a specific
antibiotic either by giving a generic/brand name or
showing a used package:
“Not many people ask for advice, they usually come
to buy specific drugs (…) When they want to buy
antibiotics, they usually ask for amoxicillin.” (Female
pharmacy attendant, Bekasi, V014B)
“Many customers were prescribed antibiotics from
the primary health centre and then they buy [the
same antibiotic] from us. They remember the name
and mention it to us.” (Male pharmacist, Bekasi,
V05B)
“They come into my shop and say what they want
to buy, like ‘I want amoxicillin and paratusin [a
cough and cold medicine]’.” (Female pharmacist,
Bekasi, V013B).
These accounts were mirrored in interviews with
customers:
“How did you first get the antibiotics? From the
physician at the primary health centre, I was sick
and given prescription. A long time ago? Yes. Did
you buy the same medicine again? Yes, but I no
longer visit the health centre for consultations.”
(Male client, 39, Tabalong, C05T)
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“Some time ago I got the medicine with the doctor’s
prescription. And then it was finished, so I bought it
again (…) I usually bring the used package, or I tell
the name.” (Female client, 39, Bekasi, C07B)
“I bought amoxicillin at the drug store, with no pre-
scription. I brought sample package from my neigh-
bour – I was told that I can get the medicine at the
drug store or pharmacy.” (Female client, 47 Bekasi,
C015B)
A less common pattern involved pharmacists recom-
mending an antibiotic, often based on a brief assessment
of the patient:
“I will suggest antibiotics to those who look sick, for
example those with toothache or respiratory infec-
tion…” (Female pharmacist, Bekasi, V012B)
“I recommend antibiotics only if there are signs of
infection.” (Female pharmacist, Tabalong, V03T)
Lastly, some pharmacists said that they would refer cli-
ents with severe symptoms to health care facilities, espe-
cially when the patient was a child:
“If the patient is really unwell, I would recommend
them to go to the hospital, for example if a child
has fever for more than 3 days.” (Male pharmacist,
Tabalong, V012T).
Drivers of inappropriate antibiotic dispensing
In addition to the interactions between clients and ven-
dors concerning the sale of antibiotics, the interviews
sought to explore factors that shaped these interactions
and their outcomes. These factors are described in turn
below.
Misconceptions about antibiotics
Lack of knowledge or misinformation about antibiotics
were common in the study locations. Many vendors had
no training in pharmacy and were not aware of AMR. In
addition, pharmacists in both Bekasi and Tabalong ex-
plained that their customers demanded antibiotics indis-
criminately for any condition:
“There are many clients asking for antibiotics,
maybe 30-40%. They want antibiotics for every-
thing… even for muscle pain…I don’t know
what’s wrong. Sometimes they are very stub-
born… if we try to explain that antibiotics should
be used for other [diseases], they often insist…
they still want them.” (Female owner/pharmacist,
Bekasi, V010B)
“Most people here believe that all diseases can be
treated with antibiotics.” (Male drug store owner,
Tabalong, V011T)
In keeping with these comments, many clients believed
that antibiotics are “powerful” (manjur) medicines that
can be used to effectively treat a common cold, inflam-
mation, toothache, cough, and even as an energy
booster:
“[Antibiotics] reduce fever faster… they improve our
antibodies.” (Female client, 28, Tabalong, C08T)
“When I have a cough, I usually take amoxicillin,
paracetamol and konidin [cold medicine]. If I only
take konidin, I don’t feel any effect. But when I mix
it with amoxicillin and paracetamol, I immediately
get better.” (Male client, 65, Tabalong, C012T)
“Why did you take amoxicillin? I often feel tired
and sleepy… I am a driver, so it is dangerous if I’m
sleepy.” (Male client, 39, Tabalong, C05T)
A few clients stated they felt ignorant or lacked know-
ledge about antibiotics and therefore were reluctant to
use them without expert advice. For example, a cus-
tomer in Bekasi said:
“I never buy such drugs [antibiotics] because I don’t
really know. If I don’t have the prescription, I don’t
want to take them.” (Male client, 60, Bekasi, C01B).
As the next citations illustrate, poor knowledge of an-
tibiotics was often associated with different forms of
malpractice such as the storage of leftover antibiotics at
home for future use.
“What kind of medicine do you keep at home?
Amoxicillin, paracetamol… How frequently do you
buy these medicines? I buy them when they run
out, sometimes every week. Do you use them for
all family members? Yes.” (Male client, 22,
Bekasi, C03B).
“When was the last time you were sick? I think 3-
4 months ago. What did you have? Nothing spe-
cial…just fever and headache. What did you do? I
immediately took antibiotics. Where did you get
them? I had some at home.” (Male client, 33, Bekasi,
C02B)
“We have medicine stock at home… When some-
body is sick, I give paracetamol and amoxicillin.
That’s all.” (Female client, 48, Tabalong, C07T)
Ferdiana et al. BMC Public Health         (2021) 21:1800 Page 5 of 10
Market competition and the unintended consequences of
health policy reform
The struggle to survive in an increasingly competitive
market was another driver of inappropriate antibiotic
dispensing. Some pharmacists reported a daily revenue
of IDR 300,000–500,000 (USD 20–30) and a net profit
of only IDR 50,000–100,000 (US$ 3–7) due to high op-
erational costs and competition. According to some par-
ticipants, the financial viability of some pharmacies had
been negatively affected by the introduction of free med-
icines under the JKN. Pharmacists who were not part of
this scheme complained they had experienced a decline
in clients and income, and were therefore more likely to
use coping strategies such as the dispensing of non-
prescribed medicines:
“I can say that pharmacies are no longer profitable,
because of the JKN. So don’t be surprised if many
pharmacies are going bankrupt.” (Male pharmacist/
owner, Tabalong, V02T)
“It has been very difficult for three years. We have
high operational costs and we make little profit… I
feel like I am volunteering… I am working only for
personal satisfaction - what we earn is not much.”
(Female pharmacist, Tabalong, V03T)
“It’s getting hard… you know… If we deny antibi-
otics, they can buy them with no prescription at
other places… and our income will decrease.” (Fe-
male pharmacist, Bekasi, V08B)
In addition, due to financial constraints, some owners
of pharmacies admitted they could no longer employ a
full-time pharmacist. In Tabalong, this problem was
compounded by challenges to attract and retain qualified
pharmacists as these would prefer to work in the cities
rather than in rural areas. As a result, pharmacies in
both locations were often staffed by unqualified atten-
dants, with little knowledge of antibiotics and regula-
tions governing their use.
Limited decision-making power of pharmacists who do not
own the pharmacy
Other pharmacists explained that inappropriate dispens-
ing could occur even when a qualified pharmacist was
available. One pharmacist in Bekasi said that this was
often a result of the power imbalance between the
pharmacist and the pharmacy owner, since the latter
had the “highest level of decision-making”, and therefore
could influence dispensing practices even when these
were not in line with the regulations. Similarly, another
pharmacist said she could not deny antibiotics without
prescription because she had no power (Female pharma-
cist/owner, Bekasi, V010B).
Weak enforcement of regulations
There was widespread consensus that the enforcement
of regulations was weak, despite the active role of profes-
sional pharmacist associations in both study locations.
In Bekasi, one drug store owner said she could sell anti-
biotics easily due to lack of supervision:
“Did you receive any visits from the district health
office recently? Never. So you can sell antibiotics eas-
ily? Yes… I can sell drugs like amoxicillin. Why
amoxicillin? Because it is a common drug every-
where.” (Female drug store owner, Bekasi, V019B)
This narrative was echoed in the views of some phar-
macists, who confirmed that dispensing practices at both
pharmacies and drug stores were not really monitored:
“There should be strict monitoring (…). Drug stores
are not supposed to sell antibiotics, but they often
have ampicillin and amoxicillin. Sometimes they
also sell cipro[floxacin] and cefadroxil although this
is less common.” (Male pharmacist, Tabalong,
V01T)
Discussion
This study sought to gain a better understanding of anti-
biotic dispensing practices at community pharmacies
and other drug stores in Indonesia. As documented in
the interviews, participants perceived that self-
medication with drugs purchased at DROs provides a
convenient and low-cost strategy to relieve symptoms.
Further, we identified two types of interactions or sce-
narios resulting in inappropriate dispensing. In the first
type, clients directly requested antibiotics without pre-
scription, either by stating their generic/brand name or
by showing an empty package or sample. In the second
scenario, which we found to be less common, vendors
“prescribed” antibiotics to clients who presented with
symptoms and asked for advice, often based on a brief
assessment (Fig. 1). As found in other studies, these two
patterns highlight the role of both direct and indirect
self-medication practices in driving inappropriate anti-
biotic use [28, 29].
Our findings also cast light on the different drivers of
inappropriate antibiotic dispensing in the study loca-
tions. On the demand side, similar to recent findings in
China [30] and Thailand [31], many participants in our
study believed that antibiotics are multi-purpose anti-
inflammatory drugs which can be used to treat almost
any condition. In general, self-medication with antibi-
otics was seen as an appropriate, affordable and
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convenient practice to relieve symptoms, while concerns
about long waiting times and costs discouraged the util-
isation of public health facilities as found in other stud-
ies [32]. On the supply side, economic challenges and
market competition, combined with widespread avail-
ability of cheap antibiotics and lack of adequate informa-
tion on AMR, induced pharmacies to sell non-
prescribed antibiotics. While some of these issues have
been highlighted in previous work in Indonesia [18, 33]
and elsewhere in Asia [34–38], a key finding in our study
is that policy reforms to improve access to affordable
services and medicines may have unintended and un-
desirable effects on pharmacy practice and, ultimately,
the control of AMR. Since the introduction of the JKN
in 2014, a substantial increase in the utilisation of public
health centres has been reported [39]. In contrast, inde-
pendent pharmacies outside the JKN network face new
challenges as many of their former clients choose to re-
ceive subsidised care (and medicines) in the public sec-
tor. As documented in some interviews, this may induce
coping strategies to minimise economic loss such as the
inappropriate dispensing of antibiotics. Thus, our study
highlights the need for stronger private sector engage-
ment in policies to promote UHC and appropriate anti-
biotic use, especially in countries such as Indonesia
where the private sector is such a popular source of
care.
Lastly, our study highlights shortcomings in the regu-
latory enforcement and monitoring of drug sales,
particularly in relation to human resources. As dis-
cussed, one important gap is that in many places quali-
fied staff are not always in attendance – a trend that is
well known in Indonesia as in other parts of Asia [34,
40]. This is a complex problem which can be associated
with multiple factors including weak supervision from
local authorities, challenges in attracting and retaining
pharmacy professionals in rural areas, and inadequate
salaries. However, in keeping with findings from India
[41, 42], our study also found that attendance by phar-
macists does not guarantee appropriate dispensing,
partly due to potential conflicts of interest between the
professional ethics of pharmacists and the economic in-
centives of those who own and manage the pharmacies.
Another reason is that some pharmacists are reluctant
to deny antibiotics to clients who ask for them, in fear
that they will take their business elsewhere. This sug-
gests that the educational curriculum for pharmacists
should be reformed to include specific training on inter-
personal communication skills to manage patient de-
mand for medications [43, 44].
In sum, the findings from this study highlight the
multi-faceted nature of AMR and the complex mix of
drivers of antibiotic dispensing in the community, invit-
ing some reflections on policy implications. In the com-
munities, recent evidence indicates that interventions to
educate pharmacists alone may be ineffective unless
these are supported by campaigns on proper antibiotic
use in the general population [45]. Given that
Fig. 1 Diagram illustrating pathways leading to inappropriate antibiotics dispensing from the perspective of patients and vendors. Boxes in blue
are cognitive processes or states. Boxes in white are actions
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community members are often introduced to the use of
antibiotics in the public sector, doctors and nurses at
public health centres could be involved in educational
campaigns, providing more information on AMR when
prescribing. Yet it is well recognised that interventions
solely focused on individual behaviour are unlikely to
succeed, given the key role of wider contextual drivers
[46]. Indeed, past experiences indicate that multi-faceted
interventions are more effective than single interventions
to reduce inappropriate antibiotic use. For example,
positive outcomes have been achieved in other LMICs
where stronger regulatory enforcement was combined
with educational programmes such as training of dis-
pensers and public awareness campaigns [47–50]. Avail-
able evidence also suggests that interventions targeted to
different stakeholders (including doctors, nurses, phar-
macists, patients, and the public) are more likely to be
effective than those that only focus on one group [51].
On the supply side, incentive systems could also be de-
vised such as renewing licenses only to those who com-
ply with the regulations and appropriately dispense
medicines. In pharmacies, this could also be a require-
ment for inclusion in public health schemes such as the
JKN network.
Study limitations
The findings presented here offer qualitative insights
into antibiotic dispensing practices and their determi-
nants in the study locations but cannot be generalised to
the whole country and beyond. In addition, all interviews
were conducted inside the pharmacies and drug stores;
in these environments, participants (both clients and
vendors) may have felt some pressure to provide socially
desirable answers and perhaps understate the extent and
willingness to engage in unauthorised practices. In
addition, this study focused on behaviour and practices
in the communities. Therefore, it did not include other
important categories of stakeholders influencing anti-
biotic dispensing such as policy makers, implementers of
programs to control AMR, and representatives of profes-
sional associations and business interests in the pharma-
ceutical sector. Lastly, a larger number of drug stores in
the study sample might have provided additional in-
sights, so we cannot be sure saturation was achieved for
this type of outlets.
Conclusion
Findings from this study reveal that inappropriate dispens-
ing of antibiotics is the outcome of a complex set of inter-
actions between vendors and clients, shaped by wider and
changing socio-economic processes. As such, it contrib-
utes knowledge and insights that can be used to refine
existing models and conceptual frameworks of behav-
ioural patterns and their determinants leading to
inappropriate dispensing [42]. In Indonesia, as in many
other LMICs with large and informal private sectors, con-
certed action should be taken to engage both pharmacies
and drug stores in plans to reduce AMR. This would help
avert unintended effects of market competition and ad-
verse policy outcomes as observed in this study.
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